Harrow
IPOPublic · Nashville, United States · Founded 2012
- Headquarters
- Nashville, Tennessee
- Employees
- 201–500
- Founded
- 2012
- Business Model
- B2B
- Website
- harrow.com
- Type
- Public
About
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company that develops, manufactures, and commercializes ophthalmic disease management solutions across North America, spanning surgical products for cataract and glaucoma procedures, LASIK and intravitreal injection treatments, and chronic care medications for dry eye disease and glaucoma. Originally founded in 2012 in San Diego as ImprimisRx, the company rebranded as Harrow in 2019, relocated its headquarters to Nashville, Tennessee, and has since grown through seven strategic acquisitions, including IHEEZO, VEVYE, and TRIESENCE.
Summary
Harrow is a Healthcare company based in Nashville, United States, founded in 2012.
Funding History
Jul 2023
Sign up to see all 2 rounds
IPO through Secondary Market — per-round amounts, valuations, and who invested in each round.
Similar Companies
BridgeBio makes targeted treatments for genetic diseases.
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
China's leading blood products manufacturer
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/harrow"><img src="https://indexed.vc/api/badge/company/harrow" alt="Harrow on Indexed.vc" width="260" height="76" /></a>